{"DataElement":{"publicId":"3902332","version":"1","preferredName":"Medical Device Chlorhexidine Gluconate Use Type","preferredDefinition":"Information related to the employment of gluconate salt form of chlorhexidine, a biguanide compound used as an antiseptic agent with topical antibacterial activity. Chlorhexidine gluconate is positively charged and reacts with the negatively charged microbial cell surface, thereby destroying the integrity of the cell membrane. Subsequently, chlorhexidine gluconate penetrates into the cell and causes leakage of intracellular components leading to cell death.","longName":"CHG_UseTp","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3902321","version":"1","preferredName":"Medical Device Chlorhexidine Gluconate Use","preferredDefinition":"Information related to the employment of gluconate salt form of chlorhexidine, a biguanide compound used as an antiseptic agent with topical antibacterial activity. Chlorhexidine gluconate is positively charged and reacts with the negatively charged microbial cell surface, thereby destroying the integrity of the cell membrane. Subsequently, chlorhexidine gluconate penetrates into the cell and causes leakage of intracellular components leading to cell death.","longName":"CHG_Use","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2541698","version":"1","preferredName":"Medical_Device","preferredDefinition":"Medical device - any machinery designed to aid diagnostic and medical therapies. Medical device has to be designed with rigorous safety standards. There are several basic types of medical devices: life support equipment used to maintain a patient's body functions; therapeutic equipment; monitors and detectors to measure the indexes of a patient's state; imagine machines and laboratory equipment used with diagnostic and status monitoring purposes. In insurance parlance, the term is usually synonymous with assistive device, although it may include medical supplies.","longName":"C16830","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical Device","conceptCode":"C16830","definition":"Any physical object that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"22243E3E-185B-0D15-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-13","modifiedBy":"ONEDATA","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3902319","version":"1","preferredName":"Chlorhexidine Gluconate Use","preferredDefinition":"The gluconate salt form of chlorhexidine, a biguanide compound used as an antiseptic agent with topical antibacterial activity. Chlorhexidine gluconate is positively charged and reacts with the negatively charged microbial cell surface, thereby destroying the integrity of the cell membrane. Subsequently, chlorhexidine gluconate penetrates into the cell and causes leakage of intracellular components leading to cell death. Since gram positive bacteria are more negatively charged, they are more sensitive to this agent.:A manner, or usual, or accepted practice of using something.","longName":"C47974:C25340","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chlorhexidine Gluconate","conceptCode":"C47974","definition":"The gluconate salt form of chlorhexidine, a biguanide compound used as an antiseptic agent with topical antibacterial activity. Chlorhexidine gluconate is positively charged and reacts with the negatively charged microbial cell surface, thereby destroying the integrity of the cell membrane. Subsequently, chlorhexidine gluconate penetrates into the cell and causes leakage of intracellular components leading to cell death. Since gram positive bacteria are more negatively charged, they are more sensitive to this agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69AF7AD-5F71-15DF-E040-BB89AD437B80","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"ONEDATA","dateModified":"2013-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69AF7AD-5F82-15DF-E040-BB89AD437B80","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3902326","version":"1","preferredName":"Chlorhexidine Gluconate Use Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities related to the employment of gluconate salt form of chlorhexidine, a biguanide compound used as an antiseptic agent with topical antibacterial activity. Chlorhexidine gluconate is positively charged and reacts with the negatively charged microbial cell surface, thereby destroying the integrity of the cell membrane. Subsequently, chlorhexidine gluconate penetrates into the cell and causes leakage of intracellular components leading to cell death.","longName":"CHG_UseTp","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E69AF7AD-5FD4-15DF-E040-BB89AD437B80","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"ONEDATA","dateModified":"2013-09-17","deletedIndicator":"No"},{"value":"Non-protocol approved CHG bathing","valueDescription":"Non-protocol approved CHG bathing","ValueMeaning":{"publicId":"3902327","version":"1","preferredName":"Non-protocol approved CHG bathing","longName":"3902327","preferredDefinition":"Non-protocol approved CHG bathing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69AF7AD-5FDE-15DF-E040-BB89AD437B80","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E69AF7AD-5FF7-15DF-E040-BB89AD437B80","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"ONEDATA","dateModified":"2013-09-17","deletedIndicator":"No"},{"value":"CHG skin preparation or bathing prior to a surgical procedure","valueDescription":"CHG skin preparation or bathing prior to a surgical procedure","ValueMeaning":{"publicId":"3902328","version":"1","preferredName":"CHG skin preparation or bathing prior to a surgical procedure","longName":"3902328","preferredDefinition":"CHG skin preparation or bathing prior to a surgical procedure","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69AF7AD-6001-15DF-E040-BB89AD437B80","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E69AF7AD-601A-15DF-E040-BB89AD437B80","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"ONEDATA","dateModified":"2013-09-17","deletedIndicator":"No"},{"value":"Bio-patch or CHG-impregnated dressings used with the central line","valueDescription":"Bio-patch or CHG-impregnated dressings used with the central line","ValueMeaning":{"publicId":"3902329","version":"1","preferredName":"Bio-patch or CHG-impregnated dressings used with the central line","longName":"3902329","preferredDefinition":"Bio-patch or CHG-impregnated dressings used with the central line","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69AF7AD-6024-15DF-E040-BB89AD437B80","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E69AF7AD-603D-15DF-E040-BB89AD437B80","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"ONEDATA","dateModified":"2013-09-17","deletedIndicator":"No"},{"value":"CHG used to clean the central line site with dressing changes","valueDescription":"CHG used to clean the central line site with dressing changes","ValueMeaning":{"publicId":"3902330","version":"1","preferredName":"CHG used to clean the central line site with dressing changes","longName":"3902330","preferredDefinition":"CHG used to clean the central line site with dressing changes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69AF7AD-6047-15DF-E040-BB89AD437B80","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E69AF7AD-6060-15DF-E040-BB89AD437B80","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"ONEDATA","dateModified":"2013-09-17","deletedIndicator":"No"},{"value":"CHG used to clean the central line hub prior to accessing it","valueDescription":"CHG used to clean the central line hub prior to accessing it","ValueMeaning":{"publicId":"3902331","version":"1","preferredName":"CHG used to clean the central line hub prior to accessing it","longName":"3902331","preferredDefinition":"CHG used to clean the central line hub prior to accessing it","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69AF7AD-606A-15DF-E040-BB89AD437B80","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E69AF7AD-6083-15DF-E040-BB89AD437B80","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"ONEDATA","dateModified":"2013-09-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3902325","version":"1","preferredName":"Chlorhexidine Gluconate Use Type","preferredDefinition":"The gluconate salt form of chlorhexidine, a biguanide compound used as an antiseptic agent with topical antibacterial activity. Chlorhexidine gluconate is positively charged and reacts with the negatively charged microbial cell surface, thereby destroying the integrity of the cell membrane. Subsequently, chlorhexidine gluconate penetrates into the cell and causes leakage of intracellular components leading to cell death. Since gram positive bacteria are more negatively charged, they are more sensitive to this agent.:To put into action or service.:Something distinguishable as an identifiable class based on common qualities.","longName":"C47974:C95018:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chlorhexidine Gluconate","conceptCode":"C47974","definition":"The gluconate salt form of chlorhexidine, a biguanide compound used as an antiseptic agent with topical antibacterial activity. Chlorhexidine gluconate is positively charged and reacts with the negatively charged microbial cell surface, thereby destroying the integrity of the cell membrane. Subsequently, chlorhexidine gluconate penetrates into the cell and causes leakage of intracellular components leading to cell death. Since gram positive bacteria are more negatively charged, they are more sensitive to this agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Use","conceptCode":"C95018","definition":"To put into action or service.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69AF7AD-5FB1-15DF-E040-BB89AD437B80","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"ONEDATA","dateModified":"2013-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69AF7AD-5FC2-15DF-E040-BB89AD437B80","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"TSANE","dateModified":"2014-05-15","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Way(s) CHG was used during th","type":"Preferred Question Text","description":"Way(s) CHG was used during the Study period:","url":null,"context":"CTEP"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E69BC681-2D97-987A-E040-BB89AD4378C8","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"TSANE","dateCreated":"2013-09-17","modifiedBy":"SBR","dateModified":"2014-01-02","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}